Immuneering Corporation (IMRX)

NASDAQ: IMRX · Real-Time Price · USD

3.220

-0.030 (-0.92%)

At close: Aug 13, 2025, 4:00 PM

3.060

-0.160 (-4.97%)

Pre-market: Aug 14, 2025, 9:14 AM EDT

Immuneering Employees

Immuneering had 66 employees as of December 31, 2024. The number of employees decreased by 2 or -2.94% compared to the previous year.

Employees

66

Change (1Y)

-2

Growth (1Y)

-2.94%

Revenue / Employee

n/a

Profits / Employee

-$941,346

Market Cap

115.87M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	66	-2	-2.94%
Dec 31, 2023	68	-5	-6.85%
Dec 31, 2022	73	9	14.06%
Dec 31, 2021	64	38	146.15%
Dec 31, 2020	26	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

IMRX News

17 hours ago - Immuneering Reports Second Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
5 weeks ago - Immuneering Granted U.S. Composition of Matter Patent for Highly Differentiated Cancer Drug Candidate Atebimetinib - GlobeNewsWire
2 months ago - Immuneering Reports Positive Overall Survival Data for Atebimetinib (IMM-1-104) from Ongoing Phase 2a Trial in First-Line Pancreatic Cancer Patients - GlobeNewsWire
2 months ago - Immuneering to Provide Updates from Phase 2a Clinical Trial of IMM-1-104 in First-Line Pancreatic Cancer Patients on Tuesday, June 17, 2025 - GlobeNewsWire
2 months ago - Immuneering to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
3 months ago - Immuneering Reports First Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
4 months ago - Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
5 months ago - Immuneering Corporation Announces Grant of Inducement Award - GlobeNewsWire